Heads of global AIDS, TB and malaria agencies reinforce call to ‘get back on track’ for Global Fund’s Sixth Replenishment
With fewer than 100 days left before the Global Fund's Replenishment Conference on October 10, we are off track from our global goal to end the epidemics of AIDS, tuberculosis (TB) and malaria. A resurgence of these epidemics will cost lives, undermine development, and threaten global health security.
DECISIONS AT THE 72nd WORLD HEALTH ASSEMBLY
WHO LAUNCHES NEW GUIDELINES TO IMPROVE COMMUNITY HEALTH WORKER PROGRAMS
After years of historic progress, the battle against malaria is stalling. There were an estimated 219 million cases in 2017, up from 217 million the year before. That was the top finding of the World Malaria Report 2018, which was released by the World Health Organization (WHO) and partners, including the Global Fund, on 19 November.
OIG investigation reveals deficiencies in Global Fund processes for procurement of HIV rapid test kits in eight countries
A proactive investigation undertaken by the Office of the Inspector General (OIG) has identified some deficiencies in the Global Fund’s processes for procuring HIV rapid diagnostic test (RDT) kits. A report on the investigation was released on 31 May 2018.
The World Health Organization (WHO) has recommended scaling up access to testing and treatment for TB infection, especially among groups who are particularly at risk, such as small children and people living with HIV. The move will expand testing and care for people with latent TB infection. Precisely what the implications of the new guidelines are for the Global Fund is not yet known.
In operationalizing its strategic initiatives, the Secretariat has ensured that each initiative has a “sharp focus” on deliverables and outcomes, with strong accountability for delivery, a spokesperson for the Secretariat says.
The Global Fund, the World Health Organization (WHO), the Stop TB Partnership and 13 countries with a high burden of TB have launched a program to find and treat an additional 1.5 million missing cases of TB by the end of 2019.
A new database is being developed in Eastern Europe and Central Asia (EECA) containing information on antiretrovirals (ARVs) in use in 15 countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Poland, the Russian Federation, Tajikistan, Ukraine and Uzbekistan.